目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Immunoassay Analyzers Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immunoassay Analyzers Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Immunoassay Analyzers Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Immunoassay Analyzers Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Chemiluminescence Immunoassays (CLIA)
4.3.1. Chemiluminescence Immunoassays (CLIA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Fluorescence Immunoassays (FIA)
4.4.1. Fluorescence Immunoassays (FIA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Radioimmunoassay
4.5.1. Radioimmunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Enzyme-Linked Immunoassay
4.6.1. Enzyme-Linked Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Consumables and Accessories
4.7.1. Consumables and Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Immunoassay Analyzers Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Immunoassay Analyzers Market: Application Movement Analysis, USD Million, 2023 & 2030
5.3. Therapeutic Drug Monitoring
5.3.1. Therapeutic Drug Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Oncology
5.5. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Cardiology
5.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Endocrinology
5.7.1. Endocrinology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Infectious Disease Testing
5.8.1. Infectious Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Autoimmune Disease
5.9.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Others
5.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Immunoassay Analyzers Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Immunoassay Analyzers Market: End Use Movement Analysis, USD Million, 2023 & 2030
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Diagnostics Laboratories
6.4.1. Diagnostics Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Research Institutes
6.5.1. Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Immunoassay Analyzers Market: Regional Estimates & Trend Analysis
7.1. Immunoassay Analyzers Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
7.2.1. North America Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. U.K.
7.3.2.1. U.K. Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. South Africa
7.6.4.1. South Africa Immunoassay Analyzers Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Siemens Healthineers AG
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. BIOMÉRIEUX
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Abbott
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. QuidelOrtho Corporation
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Sysmex Corporation
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. BD
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Thermo Fisher Scientific Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. F. Hoffmann-La Roche Ltd
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Beckman Coulter, Inc.
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. DiaSorin S.p.A.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives